Citations for
1CARTPT, GPR160
GPR160 is not a receptor of anorexigenic cocaine- and amphetamine-regulated transcript peptide.
Freitas-Lima LC, Pačesová A, Staňurová J, Šácha P, Marek A, Hubálek M, Kuneš J, Železná B, Maletínská L.
Eur J Pharmacol. Jun 15;949:175713. doi: 10.1016/j.ejphar.2023.175713. Epub 2023 Apr 11. 2023
2CARTPT
Overexpressed beta cell CART increases insulin secretion in mouse models of insulin resistance and diabetes.
Abels M, Riva M, Shcherbina L, Fischer AT, Banke E, Degerman E, Lindqvist A, Wierup N.
Peptides May;151:170747. doi: 10.1016/j.peptides.2022.170747. Epub 2022 Jan 19. 2022
3CARTPT, GPR160
Past, present and future of cocaine- and amphetamine-regulated transcript peptide.
Yosten GLC, Haddock CJ, Harada CM, Almeida-Pereira G, Kolar GR, Stein LM, Hayes MR, Salvemini D, Samson WK.
Physiol Behav. Jun 1;235:113380. doi: 10.1016/j.physbeh.2021.113380. Epub 2021 Mar 8. 2021
4CARTPT
Demystifying functional role of cocaine- and amphetamine-related transcript (CART) peptide in control of energy homeostasis: A twenty-five year expedition.
Singh A, de Araujo AM, Krieger JP, Vergara M, Ip CK, de Lartigue G.
Peptides. Jun;140:170534. doi: 10.1016/j.peptides.2021.170534. Epub 2021 Mar 20. 2021
5CARTPT, NR4A1
Nr4a1 suppresses cocaine-induced behavior via epigenetic regulation of homeostatic target genes
Carpenter MD, Hu Q, Bond AM, Lombroso SI, Czarnecki KS, Lim CJ, Song H, Wimmer ME, Pierce RC, Heller EA.
Nat Commun Jan 24;11(1):504. doi: 10.1038/s41467-020-14331-y. 2020
6CARTPT
Endogenous beta-cell CART regulates insulin secretion and transcription of beta-cell genes
Shcherbina L, Edlund A, Esguerra JL, Abels M, Zhou Y, Ottosson-Laakso E, Wollheim CB, Hansson O, Eliasson L, Wierup N.
Mol Cell Endocrinol. 15;447:52-60. doi: 10.1016/j.mce.2017.02.027. Epub 2017 Feb 24 2017
7CARTPT
CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion
Abels M, Riva M, Bennet H, Ahlqvist E, Dyachok O, Nagaraj V, Shcherbina L, Fred RG, Poon W, Sörhede-Winzell M, Fadista J, Lindqvist A, Kask L, Sathanoori R, Dekker-Nitert M, Kuhar MJ, Ahrén B, Wollheim CB, Hansson O, Tengholm A, Fex M, Renström E, Groop L, Lyssenko V, Wierup N
Diabetologia. Sep;59(9):1928-37. doi: 10.1007/s00125-016-4020-6. Epub 2016 Jun 23. 2016
8CARTPT
CART attenuates endoplasmic reticulum stress response induced by cerebral ischemia and reperfusion through upregulating BDNF synthesis and secretion.
Qiu B, Hu S, Liu L, Chen M, Wang L, Zeng X, Zhu S.
Biochem Biophys Res Commun. Jul 12;436(4):655-9. doi: 10.1016/j.bbrc.2013.05.142. Epub 2013 Jun 14. 2013
9CARTPT
Reduced CSF CART in dementia with Lewy bodies.
Schultz K, Wiehager S, Nilsson K, Nielsen JE, Lindquist SG, Hjermind LE, Andersen BB, Wallin A, Nilsson C, Petersén A.
Neurosci Lett 453(2):104-6. Epub 2009 Feb 10.PMID: 19356602 2009
10CARTPT
Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence.
Lohoff FW, Bloch PJ, Weller AE, Nall AH, Doyle GA, Buono RJ, Ferraro TN, Kampman KM, Pettinati HM, Dackis CA, Oslin DW, O'Brien CP, Berrettini WH.
Neurosci Lett 440(3):280-3. Epub 2008 May 24.PMID: 18572320 2008
11CARTPT
Impact of a CART promoter genetic variation on plasma lipid profile in a general population.
Vasseur F, Guerardel A, Barat-Houari M, Cottel D, Amouyel P, Froguel P, Helbecque N.
Mol Genet Metab 90(2):199-204. Epub 2006 Sep 27. 2007
12CARTPT
Impact of a CART promoter genetic variation on plasma lipid profile in a general population.
Vasseur F, Guérardel A, Barat-Houari M, Cottel D, Amouyel P, Froguel P, Helbecque N.
Mol Genet Metab 90(2):199-204. Epub 2006 Sep 27.PMID: 17008116 2007
13CARTPT
Structure-activity relationship of CART (cocaine- and amphetamine-regulated transcript) peptide fragments.
Maixnerová J, Hlavácek J, Blokesová D, Kowalczyk W, Elbert T, Sanda M, Blechová M, Zelezná B, Slaninová J, Maletínská L.
Peptides 28(10):1945-53. Epub 2007 Jul 27.PMID: 17766010 2007
14CARTPT
Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency.
Ahn JD, Dubern B, Lubrano-Berthelier C, Clement K, Karsenty G.
Endocrinology 147(7):3196-202. Epub 2006 Apr 13. 2006
15CARTPT
Characterization and localization of cocaine- and amphetamine-regulated transcript (CART) binding sites.
Keller PA, Compan V, Bockaert J, Giacobino JP, Charnay Y, Bouras C, Assimacopoulos-Jeannet F.
Peptides 27(6):1328-34. Epub 2005 Nov 23. 2006
16CARTPT
The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: a possible cause for obesity in humans.
Yanik T, Dominguez G, Kuhar MJ, Del Giudice EM, Loh YP.
Endocrinology 147(1):39-43. Epub 2005 Oct 6. 2006
17NKX2-5, NKX2-6, CARTPT, CART,CSX
Common arterial trunk associated with a homeodomain mutation of NKX2.6.
Heathcote K, Braybrook C, Abushaban L, Guy M, Khetyar ME, Patton MA, Carter ND, Scambler PJ, Syrris P.
Hum Mol Genet 14(5):585-93. Epub 2005 Jan 13. 2005
18CARTPT
Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family.
del Giudice EM, Santoro N, Cirillo G, D'Urso L, Di Toro R, Perrone L.
Diabetes 50(9):2157-60. 2001
19CARTPT
Hypothalamic CART is a new anorectic peptide regulated by leptin.
Kristensen P, et al.
Nature 393 : 72-76. 1998
20CARTPT
Characterization of the human cDNA and genomic DNA encoding CART : a cocaine- and amphetamine-regulated transcript.
Douglass J, et al.
Gene 169 : 241-245. 1996